Intracranial Large Artery Disease of Non-Atherosclerotic Origin: Recent Progress and Clinical Implications

키워드

참고문헌 (87)

1. Chimowitz MI, "Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis", N Engl J Med, 352, pp.1305~1316 (2005)[DOI]
2. Chimowitz MI, "Stenting versus aggressive medical therapy for intracranial arterial stenosis", N Engl J Med, 365, pp.993~1003 (2011)[DOI]
3. Leung TW, "Evolution of intracranial atherosclerotic disease under modern medical therapy", Ann Neurol, 77, pp.478~486 (2015)[DOI]
4. Wong KS, "Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study", Ann Neurol, 52, pp.74~81 (2002)[DOI]
5. Ryoo S, "Differential vascular pathophysiologic types of intracranial atherosclerotic stroke: a high-resolution wall magnetic resonance imaging study", Stroke, 46, pp.2815~2821 (2015)[DOI]
6. Swartz RH, "Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI", Neurology, 72, pp.627~634 (2009)[DOI]
7. Bodle JD, "High-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial disease", Stroke, 44, pp.287~292 (2013)[DOI]
8. Alexander MD, "High-resolution intracranial vessel wall imaging: imaging beyond the lumen", J Neurol Neurosurg Psychiatry, 87, pp.589~597 (2016)[DOI]
9. Kim JS, "Non-atherosclerotic intracranial arterial diseases", Front Neurol Neurosci, 40, pp.179~203 (2016)
10. Biller J, "Cervical arterial dissections and association with cervical manipulative therapy: a statement for healthcare professionals from the american heart association", american stroke association, 2014, pp.45, 3155~3174
11. Debette S, "Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection", Lancet Neurol, 14, pp.640~654 (2015)[DOI]
12. Sato S, "Isolated anterior cerebral artery territory infarction: dissection as an etiological mechanism", Cerebrovasc Dis, 29, pp.170~177 (2010)[DOI]
13. Schievink WI, "Spontaneous dissection of the carotid and vertebral arteries", N Engl J Med, 344, pp.898~906 (2001)[DOI]
14. Kwon JY, "Intracranial and extracranial arterial dissection presenting with ischemic stroke: lesion location and stroke mechanism", J Neurol Sci, 358, pp.371~376 (2015)[DOI]
15. Guillon B, "Internal carotid artery dissection: an update", J Neurol Sci, 153, pp.146~158 (1998)[DOI]
16. Asaithambi G, "Isolated middle cerebral artery dissection: a systematic review", Int J Emerg Med, 7, pp.44~ (2014)[DOI]
17. Kim BM, "Outcomes and prognostic factors of intracranial unruptured vertebrobasilar artery dissection", Neurology, 76, pp.1735~1741 (2011)[DOI]
18. Krex D, "Extended single nucleotide polymorphism and haplotype analysis of the elastin gene in Caucasians with intracranial aneurysms provides evidence for racially", ethnically based differences, 2004, pp.18, 104~110
19. Kuroda S, "Moyamoya disease: current concepts and future perspectives", Lancet Neurol, 7, pp.1056~1066 (2008)[DOI]
20. Takagi Y, "Histological features of middle cerebral arteries from patients treated for moyamoya disease", Neurol Med Chir (Tokyo), 47, pp.1~4 (2007)[DOI]
21. Lin R, "Clinical and immunopathological features of moyamoya disease", PLoS One, 7, pp.e36386~ (2012)[DOI]
22. Takagi Y, "Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with moyamoya disease", Neurosurgery, 60, pp.338~345 (2007)[DOI]
23. Kleinloog R, "Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review", J Neurol Neurosurg Psychiatry, 83, pp.531~536 (2012)[DOI]
24. Liu W, "Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations", Neurol Med Chir (Tokyo), 52, pp.299~303 (2012)[DOI]
25. Starke RM, "Moyamoya disorder in the United States", Neurosurgery, 71, pp.93~99 (2012)[DOI]
26. Bang OY, "Adult moyamoya disease: a burden of intracranial stenosis in East Asians", PLoS One, 10, pp.e0130663~ (2015)[DOI]
27. Chung JW, "Determinants of basal collaterals in moyamoya disease: clinical and genetic factors", Eur Neurol, 75, pp.178~185 (2016)[DOI]
28. Jong S. Kim, "Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis", 대한뇌졸중영문학회지, 18(1), pp.2~11 (2016), 대한뇌졸중학회
29. Baba T, "Novel epidemiological features of moyamoya disease", J Neurol Neurosurg Psychiatry, 79, pp.900~904 (2008)[DOI]
30. Kraemer M, "Moyamoya disease in Europeans", Stroke, 39, pp.3193~3200 (2008)[DOI]
31. Calabrese LH, "Narrative review: reversible cerebral vasoconstriction syndromes", Ann Intern Med, 146, pp.34~44 (2007)[DOI]
32. Singhal AB, "Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison", Ann Neurol, 79, pp.882~894 (2016)[DOI]
33. Hajj-Ali RA, "Primary angiitis of the CNS", Lancet Neurol, 10, pp.561~572 (2011)[DOI]
34. Lee MJ, "Blood-brain barrier breakdown in reversible cerebral vasoconstriction syndrome: implications for pathophysiology and diagnosis", Ann Neurol, 81, pp.454~466 (2017)[DOI]
35. Ducros A, "The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients", Brain, 130, pp.3091~3101 (2007)[DOI]
36. Young Jun Choi, "Vessel Wall Imaging of the Intracranial and Cervical Carotid Arteries", 대한뇌졸중영문학회지, 17(3), pp.238~255 (2015), 대한뇌졸중학회
37. Kaku Y, "Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis?", Acta Neurochir (Wien), 154, pp.2151~2157 (2012)[DOI]
38. Ryoo S, "Highresolution magnetic resonance wall imaging findings of moyamoya disease", Stroke, 45, pp.2457~2460 (2014)[DOI]
39. Yuan M, "High-resolution MR imaging of the arterial wall in moyamoya disease", Neurosci Lett, 584, pp.77~82 (2015)[DOI]
40. Mossa-Basha M, "Added value of vessel wall magnetic resonance imaging for differentiation of nonocclusive intracranial vasculopathies", Stroke, 48, pp.3026~3033 (2017)[DOI]
41. Wang M, "The contrast enhancement of intracranial arterial wall on high-resolution MRI and its clinical relevance in patients with moyamoya vasculopathy", Sci Rep, 7, pp.44264~ (2017)[DOI]
42. Kuker W, "Vessel wall contrast enhancement: a diagnostic sign of cerebral vasculitis", Cerebrovasc Dis, 26, pp.23~29 (2008)[DOI]
43. van der Kolk AG, "Intracranial vessel wall imaging at 7.0-T MRI", Stroke, 42, pp.2478~2484 (2011)[DOI]
44. van der Kolk AG, "Multi-sequence whole-brain intracranial vessel wall imaging at 7.0 tesla", Eur Radiol, 23, pp.2996~3004 (2013)[DOI]
45. Wright PJ, "Water proton T1 measurements in brain tissue at 7, 3, and 1.5 T using IR-EPI, IR-TSE, and MPRAGE: results and optimization", MAGMA, 21, pp.121~130 (2008)[DOI]
46. Deng X, "Comparison of 7.0- and 3.0-T MRI and MRA in ischemictype moyamoya disease: preliminary experience", J Neurosurg, 124, pp.1716~1725 (2016)[DOI]
47. Harteveld AA, "Quantitative intracranial atherosclerotic plaque characterization at 7T MRI: an ex vivo study with histologic validation", AJNR Am J Neuroradiol, 37, pp.802~810 (2016)[DOI]
48. Sanidas E, "Evolution of intravascular assessment of coronary anatomy and physiology: from ultrasound imaging to optical and flow assessment", Eur J Clin Invest, 43, pp.996~1008 (2013)[DOI]
49. Pavlin-Premrl D, "Advanced imaging of intracranial atherosclerosis: lessons from interventional cardiology", Front Neurol, 8, pp.387~ (2017)[DOI]
50. Majidi S, "Intracranial-derived atherosclerosis assessment: an in vitro comparison between virtual histology by intravascular ultrasonography, 7T MRI, and histopathologic findings", AJNR Am J Neuroradiol, 34, pp.2259~2264 (2013)[DOI]
51. Debette S, "Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection", Nat Genet, 47, pp.78~83 (2015)[DOI]
52. Chen SP, "Brainderived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes", PLoS One, 6, pp.e18024~ (2011)[DOI]
53. Kamada F, "A genome-wide association study identifies RNF213 as the first moyamoya disease gene", J Hum Genet, 56, pp.34~40 (2011)[DOI]
54. Liu W, "Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development", PLoS One, 6, pp.e22542~ (2011)[DOI]
55. Wu Z, "Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population", PLoS One, 7, pp.e48179~ (2012)[DOI]
56. Cecchi AC, "RNF213 rare variants in an ethnically diverse population with moyamoya disease", Stroke, 45, pp.3200~3207 (2014)[DOI]
57. Ma J, "RNF213 polymorphism and moyamoya disease: a systematic review and meta-analysis", Neurol India, 61, pp.35~39 (2013)[DOI]
58. Gallai V, "Mild hyperhomocyst(e)inemia: a possible risk factor for cervical artery dissection", Stroke, 32, pp.714~718 (2001)[DOI]
59. Pezzini A, "Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke", Stroke, 33, pp.664~669 (2002)[DOI]
60. Zhu Z, "The value of plasma fibrillin-1 level in patients with spontaneous cerebral artery dissection", Neurology, 90, pp.e732~e737 (2018)[DOI]
61. Bang OY, "Caveolin-1, ring finger protein 213, and endothelial function in moyamoya disease", Int J Stroke, 11, pp.999~1008 (2016)[DOI]
62. Ahn SH, "Isolated MCA disease in patients without significant atherosclerotic risk factors: a high-resolution magnetic resonance imaging study", Stroke, 46, pp.697~703 (2015)[DOI]
63. Kim YJ, "Nonatheroscleotic isolated middle cerebral artery disease may be early manifestation of moyamoya disease", Stroke, 47, pp.2229~2235 (2016)[DOI]
64. Park MS, "Arterial dissection as a cause of intracranial stenosis in East Asians", J Am Coll Cardiol, 70, pp.2205~2206 (2017)[DOI]
65. Kuriyama S, "Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey", Stroke, 39, pp.42~47 (2008)[DOI]
66. Miao W, "Epidemiological and clinical features of moyamoya disease in Nanjing, China", Clin Neurol Neurosurg, 112, pp.199~203 (2010)[DOI]
67. Chen PC, "Epidemiology of moyamoya disease in Taiwan: a nationwide populationbased study", Stroke, 45, pp.1258~1263 (2014)[DOI]
68. 김택균, "Epidemiology of Moyamoya Disease in Korea: Based on National Health Insurance Service Data", 대한신경외과학회지, 57(6), pp.390~395 (2015), 대한신경외과학회
69. Jung KH, "Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke)", Circ Cardiovasc Qual Outcomes, 5, pp.327~334 (2012)[DOI]
70. Kimura H, "Pathologic study of intracranial large artery atherosclerosis in 7260 autopsy cases", J Stroke Cerebrovasc Dis, 26, pp.2821~2827 (2017)[DOI]
71. Chen SP, "Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency", Ther Adv Neurol Disord, 3, pp.161~171 (2010)[DOI]
72. Chaturvedi S, "Risk factor status and vascular events in patients with symptomatic intracranial stenosis", Neurology, 69, pp.2063~2068 (2007)[DOI]
73. Jong S. Kim, "Medical Treatment of Intracranial Atherosclerosis: An Update", 대한뇌졸중영문학회지, 19(3), pp.261~270 (2017), 대한뇌졸중학회
74. Ashley Wabnitz, "Angioplasty, Stenting and Other Potential Treatments of Atherosclerotic Stenosis of the Intracranial Arteries: Past, Present and Future", 대한뇌졸중영문학회지, 19(3), pp.271~276 (2017), 대한뇌졸중학회
75. Toyoda K, "Acute reperfusion therapy and stroke care in Asia after successful endovascular trials", Stroke, 46, pp.1474~1481 (2015)[DOI]
76. 방오영, "The Pathophysiology of Moyamoya Disease: An Update", 대한뇌졸중영문학회지, 18(1), pp.12~20 (2016), 대한뇌졸중학회
77. Natarajan SK, "Endovascular treatment of patients with intracranial stenosis with moyamoya-type collaterals", J Neurointerv Surg, 3, pp.369~374 (2011)[DOI]
78. Drazin D, "Endovascular treatment for moyamoya disease in a Caucasian twin with angioplasty and Wingspan stent", Clin Neurol Neurosurg, 111, pp.913~917 (2009)[DOI]
79. Khan N, "Failure of primary percutaneous angioplasty and stenting in the prevention of ischemia in moyamoya angiopathy", Cerebrovasc Dis, 31, pp.147~153 (2011)[DOI]
80. Furie KL, "Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association", american stroke association, 2011, pp.42, 227~276
81. Singhal AB, "Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome", Neurology, 88, pp.228~236 (2017)[DOI]
82. Mandell DM, "Vessel wall MRI to differentiate between reversible cerebral vasoconstriction syndrome and central nervous system vasculitis: preliminary results", Stroke, 43, pp.860~862 (2012)[DOI]
83. Turk AS, "Influence of patient age and stenosis location on wingspan in-stent restenosis", AJNR Am J Neuroradiol, 29, pp.23~27 (2008)[DOI]
84. Miyawaki S, "Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis", occlusion, 2013, pp.44, 2894~2897
85. Bang OY, "A polymorphism in RNF213 is a susceptibility gene for intracranial atherosclerosis", PLoS One, 11, pp.e0156607~ (2016)[DOI]
86. Miki Fujimura, "Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene", 대한뇌졸중영문학회지, 16(2), pp.65~72 (2014), 대한뇌졸중학회[DOI]
87. Wen-jie Yang, "Intracranial Atherosclerosis: From Microscopy to High-Resolution Magnetic Resonance Imaging", 대한뇌졸중영문학회지, 19(3), pp.249~260 (2017), 대한뇌졸중학회